{"transactions":[{"id":5897,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-08-13T00:04:56.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5080,"source":{"system":"sec-edgar","filing":"0000318154-26-000135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000135/form4.xml","form_type":"4"}},{"id":9943,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-12T00:17:32.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":41,"price":331.11,"value":13575.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 39 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4344,"source":{"system":"sec-edgar","filing":"0000318154-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000093/form4.xml","form_type":"4"}},{"id":10045,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T01:06:02.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":2969,"price":329.59,"value":978552.71,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":2969,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":2969},"source":{"system":"sec-edgar","filing":"0000318154-26-000080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000080/form4.xml","form_type":"4"}},{"id":10044,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-08T01:06:02.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":50,"price":329.59,"value":16479.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4385,"source":{"system":"sec-edgar","filing":"0000318154-26-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000080/form4.xml","form_type":"4"}},{"id":10043,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-08T01:06:02.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":4435,"source":{"system":"sec-edgar","filing":"0000318154-26-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000080/form4.xml","form_type":"4"}},{"id":10296,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-06T00:05:41.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":38,"price":329.82,"value":12533.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 49 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":3980,"source":{"system":"sec-edgar","filing":"0000318154-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000060/form4.xml","form_type":"4"}},{"id":10295,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-06T00:05:41.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":30,"price":329.82,"value":9894.6,"ownership":{"direct":true},"balance_after":4018,"source":{"system":"sec-edgar","filing":"0000318154-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000060/form4.xml","form_type":"4"}},{"id":11789,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-19T00:26:35.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":327,"price":366.21,"value":119750.67,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4048,"source":{"system":"sec-edgar","filing":"0000318154-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000024/form4.xml","form_type":"4"}},{"id":12106,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-06T01:16:09.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 60 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4361,"source":{"system":"sec-edgar","filing":"0000318154-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000013/form4.xml","form_type":"4"}},{"id":13287,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-02-21T00:43:21.000Z","date":"2026-02-19","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":375.79,"value":375790.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 60 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":3423,"source":{"system":"sec-edgar","filing":"0000318154-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000011/form4.xml","form_type":"4"}},{"id":17464,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2025-11-08T00:54:54.000Z","date":"2025-11-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":202,"price":296.7,"value":59933.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 51 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4414,"source":{"system":"sec-edgar","filing":"0000318154-25-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000075/form4.xml","form_type":"4"}},{"id":24236,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Nqso (Right to Buy)","published_at":"2025-05-09T00:50:58.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":3585,"price":270.44,"value":969527.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026."}],"balance_after":3585,"derivative":{"exercise_price":270.44,"exercise_date":"2026-05-06","expiration_date":"2035-05-06","underlying":"Common Stock","underlying_shares":3585},"source":{"system":"sec-edgar","filing":"0001127602-25-013779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013779/form4.xml","form_type":"4"}},{"id":24235,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2025-05-09T00:50:58.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4588,"source":{"system":"sec-edgar","filing":"0001127602-25-013779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013779/form4.xml","form_type":"4"}},{"id":24377,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2025-05-07T00:07:24.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":279.69,"value":279690.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4034,"source":{"system":"sec-edgar","filing":"0001127602-25-013526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013526/form4.xml","form_type":"4"}},{"id":24376,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2025-05-07T00:07:24.000Z","date":"2025-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":37,"price":283.78,"value":10499.86,"ownership":{"direct":true},"balance_after":5034,"source":{"system":"sec-edgar","filing":"0001127602-25-013526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013526/form4.xml","form_type":"4"}},{"id":24375,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2025-05-07T00:07:24.000Z","date":"2025-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":28,"price":283.78,"value":7945.84,"ownership":{"direct":true},"balance_after":5071,"source":{"system":"sec-edgar","filing":"0001127602-25-013526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013526/form4.xml","form_type":"4"}},{"id":24469,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2025-05-03T01:24:32.000Z","date":"2025-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":18,"price":288.56,"value":5194.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 105 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5099,"source":{"system":"sec-edgar","filing":"0001127602-25-013279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013279/form4.xml","form_type":"4"}},{"id":25605,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2025-03-20T00:14:22.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":174,"price":313.71,"value":54585.54,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 111 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5117,"source":{"system":"sec-edgar","filing":"0001127602-25-010052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225010052/form4.xml","form_type":"4"}},{"id":25979,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2025-03-06T00:56:37.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 100 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5277,"source":{"system":"sec-edgar","filing":"0001127602-25-008421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225008421/form4.xml","form_type":"4"}},{"id":34152,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2024-11-07T00:45:03.000Z","date":"2024-11-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":189,"price":316.91,"value":59895.99,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Plan): 43 RSUs which will vest on 4/30/2025; 509 RSUs which will vest on 11/5/2025; 144 RSUs which will vest in installments of 71 on 5/2/2025, and 73 on 5/2/2026; 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027; and 333 RSUs which will vest in installments of 109 on 5/7/2026, 110 on 5/7/2027, and 114 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 90 Dividend Equivalents (DEs) granted pursuant to the Company's Equity Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4770,"source":{"system":"sec-edgar","filing":"0001127602-24-026627","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224026627/form4.xml","form_type":"4"}},{"id":41080,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Nqso (Right to Buy)","published_at":"2024-05-09T23:00:59.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":2163,"price":300.302,"value":649553.226,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively."}],"balance_after":2163,"derivative":{"exercise_price":300.3,"exercise_date":"2026-05-07","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":2163},"source":{"system":"sec-edgar","filing":"0001127602-24-014851","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014851/form4.xml","form_type":"4"}},{"id":41079,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2024-05-09T23:00:59.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 43 RSUs which will vest on 4/30/2025; 1,003 RSUs which will vest in installments of 494 on 11/5/2024 and 509 on 11/5/2025; 144 RSUs which will vest in installments of 71 on 5/2/2025, and 73 on 5/2/2026; 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027; and 333 RSUs which will vest in installments of 109 on 5/7/2026, 110 on 5/7/2027, and 114 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 112 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4932,"source":{"system":"sec-edgar","filing":"0001127602-24-014851","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014851/form4.xml","form_type":"4"}},{"id":41217,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2024-05-08T00:31:19.000Z","date":"2024-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":27,"price":311.29,"value":8404.83,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 43 RSUs which will vest on 4/30/2025; 1,003 RSUs which will vest in installments of 494 on 11/5/2024 and 509 on 11/5/2025; 144 RSUs which will vest in installments of 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 112 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4599,"source":{"system":"sec-edgar","filing":"0001127602-24-014505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014505/form4.xml","form_type":"4"}},{"id":41274,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2024-05-07T00:24:21.000Z","date":"2024-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":27,"price":277.37,"value":7488.99,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 64 RSUs which will vest on 5/5/2024; 43 RSUs which will vest on 4/30/2025; 1,003 RSUs which will vest in installments of 494 on 11/5/2024 and 509 on 11/5/2025; 144 RSUs which will vest in installments of 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 121 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4626,"source":{"system":"sec-edgar","filing":"0001127602-24-014351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014351/form4.xml","form_type":"4"}},{"id":41592,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2024-05-01T23:50:46.000Z","date":"2024-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":17,"price":276.38,"value":4698.46,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 64 RSUs which will vest on 5/5/2024; 43 RSUs which will vest on 4/30/2025; 1,003 RSUs which will vest in installments of 494 on 11/5/2024 and 509 on 11/5/2025; 214 RSUs which will vest in installments of 70 on 5/2/2024, 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 125 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4653,"source":{"system":"sec-edgar","filing":"0001127602-24-013810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224013810/form4.xml","form_type":"4"}},{"id":42715,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2024-03-20T23:59:27.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":146,"price":268.87,"value":39255.02,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 64 RSUs which will vest on 5/5/2024; 84 RSUs which will vest in installments of 41 on 4/30/2024 and 43 on 4/30/2025; 1,003 RSUs which will vest in installments of 494 on 11/5/2024 and 509 on 11/5/2025; 214 RSUs which will vest in installments of 70 on 5/2/2024, 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 129 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4670,"source":{"system":"sec-edgar","filing":"0001127602-24-010847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224010847/form4.xml","form_type":"4"}},{"id":43701,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2024-03-08T22:24:21.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 64 RSUs which will vest on 5/5/2024; 84 RSUs which will vest in installments of 41 on 4/30/2024 and 43 on 4/30/2025; 1,003 RSUs which will vest in installments of 494 on 11/5/2024 and 509 on 11/5/2025; 214 RSUs which will vest in installments of 70 on 5/2/2024, 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 115 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4799,"source":{"system":"sec-edgar","filing":"0001127602-24-009238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224009238/form4.xml","form_type":"4"}},{"id":51507,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2023-11-08T01:12:31.000Z","date":"2023-11-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":183,"price":269.86,"value":49384.38,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 64 RSUs which will vest on 5/5/2024; 84 RSUs which will vest in installments of 41 on 4/30/2024 and 43 on 4/30/2025; 1,003 RSUs which will vest in installments of 494 on 11/5/2024 and 509 on 11/5/2025; 214 RSUs which will vest in installments of 70 on 5/2/2024, 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 101 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4367,"source":{"system":"sec-edgar","filing":"0001127602-23-026975","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223026975/form4.xml","form_type":"4"}},{"id":51506,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2023-11-08T01:12:31.000Z","date":"2023-11-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":66,"price":269.86,"value":17810.76,"ownership":{"direct":true},"balance_after":4550,"source":{"system":"sec-edgar","filing":"0001127602-23-026975","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223026975/form4.xml","form_type":"4"}}]}